Bausch + Lomb Separates From Bausch Health After Delivering Its Only First-Quarter Sales Growth

Bausch Health closed Bausch + Lomb IPO offering 10% of shares instead of 20% planned. Bausch + Lomb’s $889m Q1 revenue up 1% while other Bausch Health divisions slumped.

• Source: Shutterstock

The business Bausch & Lomb Inc. separated in an initial public offering of shares which closed on 10 May was its only segment with positive results during its latest quarter, according to its earnings announcement published the same day.

Eye health and vision care firm Bausch + Lomb Corp.’s IPO closed after selling 10% of its shares, half of...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Archive

More from HBW Insight